全文获取类型
收费全文 | 20832篇 |
免费 | 1291篇 |
国内免费 | 73篇 |
专业分类
耳鼻咽喉 | 331篇 |
儿科学 | 1126篇 |
妇产科学 | 498篇 |
基础医学 | 1794篇 |
口腔科学 | 368篇 |
临床医学 | 1657篇 |
内科学 | 4967篇 |
皮肤病学 | 331篇 |
神经病学 | 1040篇 |
特种医学 | 899篇 |
外科学 | 3695篇 |
综合类 | 491篇 |
一般理论 | 3篇 |
预防医学 | 1093篇 |
眼科学 | 908篇 |
药学 | 1554篇 |
2篇 | |
中国医学 | 71篇 |
肿瘤学 | 1368篇 |
出版年
2023年 | 164篇 |
2022年 | 340篇 |
2021年 | 762篇 |
2020年 | 403篇 |
2019年 | 605篇 |
2018年 | 708篇 |
2017年 | 490篇 |
2016年 | 499篇 |
2015年 | 508篇 |
2014年 | 788篇 |
2013年 | 989篇 |
2012年 | 1496篇 |
2011年 | 1355篇 |
2010年 | 855篇 |
2009年 | 673篇 |
2008年 | 998篇 |
2007年 | 1028篇 |
2006年 | 952篇 |
2005年 | 890篇 |
2004年 | 793篇 |
2003年 | 682篇 |
2002年 | 602篇 |
2001年 | 485篇 |
2000年 | 511篇 |
1999年 | 408篇 |
1998年 | 185篇 |
1997年 | 161篇 |
1996年 | 134篇 |
1995年 | 139篇 |
1994年 | 124篇 |
1993年 | 115篇 |
1992年 | 283篇 |
1991年 | 253篇 |
1990年 | 228篇 |
1989年 | 228篇 |
1988年 | 193篇 |
1987年 | 210篇 |
1986年 | 176篇 |
1985年 | 188篇 |
1984年 | 155篇 |
1983年 | 153篇 |
1982年 | 71篇 |
1981年 | 87篇 |
1980年 | 73篇 |
1979年 | 117篇 |
1978年 | 93篇 |
1974年 | 75篇 |
1973年 | 110篇 |
1972年 | 100篇 |
1971年 | 69篇 |
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
991.
便秘宁对便秘小鼠排便作用的影响 总被引:7,自引:0,他引:7
目的 探讨便秘宁对便秘小鼠排便作用的影响。方法 观察不同剂量的便秘宁对正常小鼠、燥结失水便秘模型小鼠肠运动的影响。结果 与对照组相比,不同剂量便秘宁颗粒使燥结失水便秘模型小鼠碳末推进率明显提高(P〈0.01),首次捧便时间明显缩短(P〈0.01),8小时内排便粒数增多(P〈0.05),并能使DC便秘模型小鼠12小时内干、稀粪点数明显增多(P〈0.05)。而大剂量便秘宁颗粒对燥结失水模型及DC模型上述指标与聚乙二醇4000(PEG4000)组相比差异有显著性(P〈0.05)。论讨 便秘宁颗粒能增强便秘小鼠肠运动,大剂量便秘宁对便秘模型小鼠排便作用优于聚乙二醇4000。 相似文献
992.
993.
With the use of two-dimensional echocardiography (2DE), we analyzed apical and subcostal four-chamber views for evaluation of right ventricular (RV) function in 30 individuals as compared to RV ejection fraction (RVEF) obtained by radionuclide angiography. In addition to previously reported parameters of changes in areas and chords, a new simple measurement of tricuspid annular excursion was correlated with RVEF. A close correlation was noted between tricuspid annular plane systolic excursion (TAPSE) and RVEF (r = 0.92). The RV end-diastolic area (RVEDA) and percentage of systolic change in area in the apical four-chamber view also showed close correlation with RVEF (r = -0.76 and 0.81); however, the entire RV endocardium could only be traced in about half of our patients. The end-diastolic transverse chord length and the percentage of systolic change in chord length in the apical view showed a poor correlation with RVEF. The correlation between RVEF and both areas and chords measured in the subcostal view was poor. It is concluded that the measurement of TAPSE offers a simple echocardiographic parameter which reflects RVEF. This measurement is not dependent on either geometric assumptions or traceable endocardial edges. When the endocardial outlines could be traced, the apical four-chamber view was superior to the subcostal view in assessment of RV function. 相似文献
994.
Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen 总被引:10,自引:0,他引:10
下载免费PDF全文
![点击此处可从《Gut》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Shah AA Thjodleifsson B Murray FE Kay E Barry M Sigthorsson G Gudjonsson H Oddsson E Price AB Fitzgerald DJ Bjarnason I 《Gut》2001,48(3):339-346
BACKGROUND: Selective inhibitors of cyclooxygenase (COX)-2 may provoke less gastric damage and platelet inhibition than conventional non-steroidal anti-inflammatory drugs. AIMS: We compared the biochemical and gastrointestinal effects of nimesulide, a potent and selective COX-2 inhibitor, with naproxen which exhibits no selectivity. SUBJECTS: Thirty six healthy volunteers were randomised to nimesulide 100 mg or naproxen 500 mg twice daily for two weeks in a double blind, crossover study with a washout between treatments. METHODS: Gastrointestinal side effects were assessed by endoscopy, and by estimation of small intestinal absorption-permeability and inflammation. Comparisons were made between variables at the end of each treatment phase. RESULTS: Nimesulide caused significantly less gastric injury using the modified Lanza score (p<0.001) as well as reduced duodenum injury (p=0.039). Nimesulide had lower visual analogue scores (VAS) for haemorrhage and erosive lesions in the stomach (p<0.001) and for mucosal injection in the duodenum (p=0.039). Naproxen increased excretion of calprotectin, a marker of intestinal inflammation (5.5 (1.2) to 12.1 (2.1) mg/l) while nimesulide had no effect (treatment difference p=0.03). Naproxen abolished platelet aggregation to arachidonic acid and suppressed serum thromboxane B(2) (TXB(2)) by 98%, indices of COX-1 activity. In contrast, nimesulide had no significant effect on platelet aggregation, although it reduced serum TXB(2) by 29%. Production of prostaglandin E(2) and prostacyclin by gastric biopsies, also COX-1 dependent, was inhibited by naproxen, but not by nimesulide. COX-2 activity, determined as endotoxin induced prostaglandin E(2) formation in plasma, was markedly suppressed by both treatments. INTERPRETATION: Nimesulide has preferential selectivity for COX-2 over COX-1 in vivo at full therapeutic doses and induces less gastrointestinal damage than that seen with naproxen in the short term. 相似文献
995.
Matthew C. Konerman Joshua C. Greenberg Theodore J. Kolias James R. Corbett Ravi V. Shah Venkatesh L. Murthy Scott L. Hummel 《Journal of cardiac failure》2018,24(2):90-100
Introduction
Coronary microvascular dysfunction (MVD) may contribute to the pathogenesis of heart failure with preserved ejection fraction (HFpEF). Using myocardial flow reserve (MFR) measured by positron emission tomography (PET) as an assessment of microvascular function, we hypothesized that abnormal MFR is associated with LV diastolic dysfunction (DD) and reduced LV and LA strain in patients with risk factors for HFpEF and normal epicardial perfusion on cardiac PET.Methods and Results
Retrospective study of patients without heart failure who underwent cardiac rubidium-82 PET and echocardiography. Global MFR was calculated as the ratio of global stress to rest myocardial blood flow. Echocardiographic measures of diastolic function were recorded. Global longitudinal LA and LV strain were measured with a 2-dimensional speckle-tracking technique. Relationships among MFR and echocardiographic measures were assessed with linear regression, analysis of variance, and test for trend. Seventy-three patients (age 64 ± 11 years, 52% male) were identified with no epicardial perfusion defect on cardiac PET and an ejection fraction ≥50%. Decreased MFR was associated with LV DD (P = .02) and increased E/e', an estimation of LV filling pressure (low E/e' [<8] vs. high E/e' [>15], P < .001). MFR was associated with LA strain independent of age, gender, and common comorbidities (adjusted β = 2.6% per unit MFR, P = 0.046); however, MFR was only marginally related to LV strain.Conclusions
In patients with risk factors for HFpEF, MVD assessed with MFR was associated with DD, increased estimated LV filling pressure, and abnormal LA strain. 相似文献996.
Simone Romano Robert M. Judd Raymond J. Kim Han W. Kim Igor Klem John F. Heitner Dipan J. Shah Jennifer Jue Brent E. White Raksha Indorkar Chetan Shenoy Afshin Farzaneh-Far 《JACC: Cardiovascular Imaging》2018,11(10):1419-1429
Objectives
The aim of this study was to evaluate the prognostic value of cardiac magnetic resonance (CMR) feature-tracking–derived global longitudinal strain (GLS) in a large multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy.Background
Direct assessment of myocardial fiber deformation with GLS using echocardiography or CMR feature tracking has shown promise in providing prognostic information incremental to ejection fraction (EF) in single-center studies. Given the growing use of CMR for assessing persons with left ventricular (LV) dysfunction, we hypothesized that feature-tracking–derived GLS may provide independent prognostic information in a multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy.Methods
Consecutive patients at 4 U.S. medical centers undergoing CMR with EF <50% and ischemic or nonischemic dilated cardiomyopathy were included in this study. Feature-tracking GLS was calculated from 3 long-axis cine-views. The primary endpoint was all-cause death. Cox proportional hazards regression modeling was used to examine the association between GLS and death. Incremental prognostic value of GLS was assessed in nested models.Results
Of the 1,012 patients in this study, 133 died during median follow-up of 4.4 years. By Kaplan-Meier analysis, the risk of death increased significantly with worsening GLS tertiles (log-rank p < 0.0001). Each 1% worsening in GLS was associated with an 89.1% increased risk of death after adjustment for clinical and imaging risk factors including EF and late gadolinium enhancement (LGE) (hazard ratio [HR]:1.891 per %; p < 0.001). Addition of GLS in this model resulted in significant improvement in the C-statistic (0.628 to 0.867; p < 0.0001). Continuous net reclassification improvement (NRI) was 1.148 (95% confidence interval: 0.996 to 1.318). GLS was independently associated with death after adjustment for clinical and imaging risk factors (including EF and late gadolinium enhancement) in both ischemic (HR: 1.942 per %; p < 0.001) and nonischemic dilated cardiomyopathy subgroups (HR: 2.101 per %; p < 0.001).Conclusions
CMR feature-tracking–derived GLS is a powerful independent predictor of mortality in a multicenter population of patients with ischemic or nonischemic dilated cardiomyopathy, incremental to common clinical and CMR risk factors including EF and LGE. 相似文献997.
Han S. Lim Mélèze Hocini Remi Dubois Arnaud Denis Nicolas Derval Stephan Zellerhoff Seigo Yamashita Benjamin Berte Saagar Mahida Yuki Komatsu Matthew Daly Laurence Jesel Carole Pomier Valentin Meillet Sana Amraoui Ashok J. Shah Hubert Cochet Frédéric Sacher Michel Haïssaguerre 《Journal of the American College of Cardiology》2017,69(10):1257-1269
Background
The underlying mechanisms sustaining human persistent atrial fibrillation (PsAF) is poorly understood.Objectives
This study sought to investigate the complexity and distribution of AF drivers in PsAF of varying durations.Methods
Of 135 consecutive patients with PsAF, 105 patients referred for de novo ablation of PsAF were prospectively recruited. Patients were divided into 3 groups according to AF duration: PsAF presenting in sinus rhythm (AF induced), PsAF <12 months, and PsAF >12 months. Patients wore a 252-electrode vest for body surface mapping. Localized drivers (re-entrant or focal) were identified using phase-mapping algorithms.Results
In this patient cohort, the most prominent re-entrant driver regions included the pulmonary vein (PV) regions and inferoposterior left atrial wall. Focal drivers were observed in 1 or both PV regions in 75% of patients. Comparing between the 3 groups, with longer AF duration AF complexity increased, reflected by increased number of re-entrant rotations (p < 0.05), number of re-entrant rotations and focal events (p < 0.05), and number of regions harboring re-entrant (p < 0.01) and focal (p < 0.05) drivers. With increased AF duration, a higher proportion of patients had multiple extra-PV driver regions, specifically in the inferoposterior left atrium (p < 0.01), superior right atrium (p < 0.05), and inferior right atrium (p < 0.05). Procedural AF termination was achieved in 70% of patients, but decreased with longer AF duration.Conclusions
The complexity of AF drivers increases with prolonged AF duration. Re-entrant and focal drivers are predominantly located in the PV antral and adjacent regions. However, with longer AF duration, multiple drivers are distributed at extra-PV sites. AF termination rate declines as patients progress to longstanding PsAF, underscoring the importance of early intervention. 相似文献998.
Left ventricular deformation at rest predicts exercise‐induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea
下载免费PDF全文
![点击此处可从《European journal of heart failure》网站下载免费的PDF全文](/ch/ext_images/free.gif)
999.
Challenges in Patient Enrollment and Retention in Clinical Studies for Alcoholic Hepatitis: Experience of the TREAT Consortium
下载免费PDF全文
![点击此处可从《Alcoholism, clinical and experimental research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Megan Comerford Spencer Lourens Suthat Liangpunsakul Naga P. Chalasani Arun J. Sanyal Vijay H. Shah Patrick S. Kamath Puneet Puri Barry P. Katz Svetlana Radaeva David W. Crabb 《Alcoholism, clinical and experimental research》2017,41(12):2000-2006
The TREAT Consortium has carried out clinical studies on alcoholic hepatitis (AH) for over 4 years. We encountered problems with participant recruitment, retention, and eligibility for specific protocols. To improve our ability to carry out such trials, we reviewed recruitment screening logs, end of study logs, and surveyed study coordinators to learn the reasons for missing patients, why patients declined enrollment, and the number of patients eligible for treatment trials. Associations of the recruited subjects’ demographics with their adherence to follow‐up appointments were examined. Three hundred eight‐seven patients (AH and heavy drinking controls) were enrolled in the observational study, and 55 AH patients were recruited into treatment trials. About half of patients identified with AH could not be recruited; no specific reason could be determined for about two‐thirds of these. Among the patients who gave a reason for not participating, the most common reasons were feeling too sick to participate, desire to concentrate on abstinence, and lack of interest in research. Approximately a quarter of the AH patients met eligibility criteria for treatment trials for moderate or severe AH and we were able to recruit half to two‐thirds of those eligible. Approximately 35% of participants in the observational study returned for both 6‐ and 12‐month follow‐up visits. We did not identify biopsychosocial or demographic correlates of retention in the study. This analysis revealed that attempts at recruitment into trials for AH miss some subjects because of structural issues surrounding their hospital admission, and encounter a high rate of patient refusal to participate. Nonetheless, more than half of the patients who met the eligibility criteria for moderate or severe AH were entered into clinical trials. Retention rates for the observational study are relatively low. These findings need to be accounted for in clinical trial design and power analysis. 相似文献
1000.
Validation of the HFA‐PEFF score for the diagnosis of heart failure with preserved ejection fraction